In the PANORAMA-HF trial, children receiving sacubitril/valsartan for their heart failure experienced clinically meaningful improvements similar to those seen in children receiving enalapril, although ...

Renowned visionary English physician William Harvey wrote in 1651 about how our blood contains all the secrets of life. “And so I conclude that blood lives and is nourished of itself and in no way ...

When the patient arrived, she was breathing faster than normal and had been progressively tired and sweaty when feeding. Her temperature was 97.7 °F, with pulse of 175, respiration 70, blood pressure ...

BUFFALO, N.Y. — A genetic variant is likely putting some children suffering with myocarditis — inflammation of the heart muscle — at higher risk of developing heart failure, which can be fatal, ...

A genetic variant is likely putting some children suffering with myocarditis — inflammation of the heart muscle — at higher risk of developing heart failure, which can be fatal, according to a study ...

Australia's Murdoch Children's Research Institute is helping scientists use stem cell medicine and artificial intelligence to develop precision therapies for pediatric heart disease, the leading cause ...

Although you may not think of children when you imagine someone with heart problems, congenital heart defects are actually the most common birth defect in the U.S., occurring in about 1% of births.

NEW HYDE PARK, N.Y.--(BUSINESS WIRE)--Cohen Children’s Medical Center (CCMC) performed its first pediatric heart transplant on March 28, just weeks after receiving approval from the state. The ...

The US Food and Drug Administration (FDA) has approved sacubitril/valsartan (Entresto, Novartis) for the treatment of symptomatic heart failure (HF) with systemic left ventricular systolic dysfunction ...

Texas Children's Hospital doctors and nurses born with heart defects are now treating kids enduring the same challenges.